Found: 94
Select item for more details and to access through your institution.
Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome.
- Published in:
- Journal of Patient-Reported Outcomes, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1186/s41687-019-0153-y
- By:
- Publication type:
- Article
Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 5, p. 266, doi. 10.1159/000362430
- By:
- Publication type:
- Article
Practical Management of Everolimus-Related Toxicities in Patients with Advanced Solid Tumors.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 5, p. 295, doi. 10.1159/000350625
- By:
- Publication type:
- Article
Regional socioeconomic deprivation associated with the use of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists in adults with type 2 diabetes in Germany.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 4116, doi. 10.1111/dom.15741
- By:
- Publication type:
- Article
Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon‐like peptide‐1 receptor agonist: A retrospective analysis of the Diabetes Prospective Follow‐Up Registry.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1813, doi. 10.1111/dom.15038
- By:
- Publication type:
- Article
Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow‐up (Germany/Austria) registries.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1577, doi. 10.1111/dom.14069
- By:
- Publication type:
- Article
Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids.
- Published in:
- EJNMMI Research, 2015, v. 5, n. 1, p. 1, doi. 10.1186/s13550-015-0130-2
- By:
- Publication type:
- Article
Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids.
- Published in:
- EJNMMI Research, 2015, v. 5, n. 1, p. 1, doi. 10.1186/s13550-015-0130-2
- By:
- Publication type:
- Article
<sup>68</sup>Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 5, p. 697, doi. 10.2967/jnumed.110.083741
- By:
- Publication type:
- Article
429-P: Therapeutic Inertia: Gap between Goals and Achievement between the T1DX and DPV Registries.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-429-P
- By:
- Publication type:
- Article
Gastrointestinale neuroendokrine Tumoren – Update 2024.
- Published in:
- Innere Medizin (2731-7080), 2024, v. 65, n. 7, p. 664, doi. 10.1007/s00108-024-01734-y
- By:
- Publication type:
- Article
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01018-w
- By:
- Publication type:
- Article
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 5, p. 1348, doi. 10.1245/s10434-019-08049-5
- By:
- Publication type:
- Article
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Renal neuroendocrine tumors: clinical and molecular pathology with an emphasis on frequent association with ectopic Cushing syndrome.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 4, p. 465, doi. 10.1007/s00428-023-03596-5
- By:
- Publication type:
- Article
Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 3, p. 507, doi. 10.1007/s00428-022-03484-4
- By:
- Publication type:
- Article
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neuropathy in paediatric type 1 diabetes mellitus – clinical characterization and analysis of risk factors in the diabetes prospective follow-up registry DPV (Diabetes-Patienten-Verlaufsdokumentation)-registry.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2023, v. 36, n. 7, p. 628, doi. 10.1515/jpem-2023-0074
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.249136
- By:
- Publication type:
- Article
Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e643, doi. 10.1093/oncolo/oyad325
- By:
- Publication type:
- Article
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 940, doi. 10.1093/oncolo/oyac161
- By:
- Publication type:
- Article
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1082, doi. 10.1634/theoncologist.2018-0672
- By:
- Publication type:
- Article
Long‐Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. e662, doi. 10.1634/theoncologist.2018-0236
- By:
- Publication type:
- Article
Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 463, doi. 10.1634/theoncologist.2018-0217
- By:
- Publication type:
- Article
Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 409, doi. 10.1634/theoncologist.2016-0351
- By:
- Publication type:
- Article
Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT‐3 and RADIANT‐4 trials.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2674, doi. 10.1002/cncr.33540
- By:
- Publication type:
- Article
Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study.
- Published in:
- Endocrine (1355008X), 2021, v. 71, n. 2, p. 502, doi. 10.1007/s12020-020-02475-2
- By:
- Publication type:
- Article
Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas.
- Published in:
- Clinical Endocrinology, 2005, v. 62, n. 4, p. 434, doi. 10.1111/j.1365-2265.2005.02238.x
- By:
- Publication type:
- Article
Neuroendocrine tumors of midgut and hindgut origin: Tumor-node-metastasis classification determines clinical outcome.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 15, p. 3332, doi. 10.1002/cncr.25855
- By:
- Publication type:
- Article
Everolimus-induced pneumonitis in neuroendocrine neoplasms: correlation of CT findings and clinical signs.
- Published in:
- Acta Radiologica, 2021, v. 62, n. 8, p. 1006, doi. 10.1177/0284185120950100
- By:
- Publication type:
- Article
Optimized imaging of the lower abdomen and pelvic region in hepatocyte-specific MRI: evaluation of a whole-abdomen first-pass shuttle protocol in patients with neuroendocrine neoplasms.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 12, p. 3741, doi. 10.1210/jc.2011-0666
- By:
- Publication type:
- Article
Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 9, p. 2427, doi. 10.1245/s10434-010-1006-3
- By:
- Publication type:
- Article
La nécessité d'un traitement personnalisé.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2017, v. 24, n. 9, p. 979, doi. 10.1684/hpg.2017.1529
- By:
- Publication type:
- Article
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2372, doi. 10.1007/s00259-020-04709-x
- By:
- Publication type:
- Article
Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 4, p. 881, doi. 10.1007/s00259-019-04439-9
- By:
- Publication type:
- Article
Role of Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 9, p. 1593, doi. 10.1007/s00259-016-3331-7
- By:
- Publication type:
- Article
Use and perceived utility of [<sup>18</sup>F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 1, p. 1, doi. 10.1111/jne.13359
- By:
- Publication type:
- Article
Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 6, p. 1, doi. 10.1111/jne.13310
- By:
- Publication type:
- Article
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 3, p. 1, doi. 10.1111/jne.13249
- By:
- Publication type:
- Article
The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 10, p. 1, doi. 10.1111/jne.13196
- By:
- Publication type:
- Article
High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 10, p. 1, doi. 10.1111/jne.13193
- By:
- Publication type:
- Article